These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 11498390)

  • 21. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.
    Hall AP; Westwood FR; Wadsworth PF
    Toxicol Pathol; 2006; 34(2):131-47. PubMed ID: 16537292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12.
    Masiero L; Figg WD; Kohn EC
    Angiogenesis; 1997; 1(1):23-35. PubMed ID: 14517390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal formulations of anticancer drugs: selectivity and effectiveness.
    Massing U; Fuxius S
    Drug Resist Updat; 2000 Jun; 3(3):171-177. PubMed ID: 11498382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current Concepts in Multi-Modality Imaging of Solid Tumor Angiogenesis.
    Soliman MA; Guccione J; Reiter AM; Moawad AW; Etchison A; Kamel S; Khatchikian AD; Elsayes KM
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33153067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor angiogenesis: insights and innovations.
    Nussenbaum F; Herman IM
    J Oncol; 2010; 2010():132641. PubMed ID: 20445741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent patents in angiogenesis research.
    Nat Biotechnol; 1999 Dec; 17(12):1231. PubMed ID: 10585726
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of biochemical factors in blood serum of patients with oral squamous cell carcinoma.
    Keshani F; Mahmoodi A; Gholami M; Azmoudeh F
    Dent Res J (Isfahan); 2023; 20():81. PubMed ID: 37674571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The comparative study of serum iron, copper, and zinc levels between bladder cancer patients and a control group.
    Mazdak H; Yazdekhasti F; Movahedian A; Mirkheshti N; Shafieian M
    Int Urol Nephrol; 2010 Mar; 42(1):89-93. PubMed ID: 19548109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis and Cancer Control: From Concept to Therapeutic Trial.
    Brem S
    Cancer Control; 1999 Oct; 6(5):436-458. PubMed ID: 10758576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer and antiangiogenic therapy: what can be expected in clinical practice?
    Mancuso A; Sternberg CN
    Crit Rev Oncol Hematol; 2005 Jul; 55(1):67-81. PubMed ID: 15890525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis inhibition in solid tumors.
    Rosen LS
    Cancer J; 2001; 7 Suppl 3():S120-8. PubMed ID: 11779082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-angiogenesis therapy:concepts and importance of dosing schedules in clinical trials.
    Mross K
    Drug Resist Updat; 2000 Aug; 3(4):223-235. PubMed ID: 11498390
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.